ImmunoPrecise Begins Path to NASDAQ

This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to dual list their stock on the NASDAQ. In the news release, the company states they believe the move will gain greater exposure for the company to access a larger base of retail and institutional investors in the United States and internationally.

ImmunoPrecise Antibodies Ltd. Logo (CNW Group/ImmunoPrecise Antibodies Ltd.)

ImmunoPrecise is a full-service, therapeutic antibody discovery company utilizing species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe. IPA has developed a technology platform with end-to-end solutions empowering companies to discover and develop therapies against any disease. Their full-service capabilities reduce the time and risk associated with conventional multi-vendor product development.

The company has been working on COVID by identifying antibodies derived from multiple species (human, llama, Ligand’s humanized OmniRat, and wild-type rabbits) which demonstrate potent, in vitro neutralizing activity. They have discovered their functional antibodies using the Company’s DeepDisplay phage technology, B Cell Select and Single Step Hybridoma platforms.

At the time of publishing IPA stock is trading at $1.85 an increase of 3.9%.

Canadian Copper Inc. — sponsored Sponsored · Canadian Copper Inc.

Information for this analysis was found via Sedar and ImmunoPrecise Antibodies Ltd. The author is long common shares of ImmunoPrecise Antibodies (IPA.v). Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Canada Raises Foreign Aid Contributions by $485 Million Towards Global Covid-19 Effort

The Canadian federal government has announced plans to increase foreign spending by pledging an additional...

Tuesday, December 15, 2020, 02:13:41 PM

This Week In China: Easing COVID Policies, Boosting Property Market, Visiting Saudi Oil

As Last Week Tonight host John Oliver would say: “it has been a busy week.”...

Friday, December 9, 2022, 10:11:29 AM

14 Million Americans Slated to Lose Unemployment Benefits, 30 Million Face Eviction Risk By January 1

The Christmas holidays are likely going to be grim for millions of Americans, and not...

Wednesday, November 25, 2020, 12:03:00 PM

FluroTech Identifies Six Sites For Its High Volume COVID-19 Antigen Test Trial

FluroTech Ltd. (TSXV: TEST) and its subsidiary FluroTest Diagnostics Systems announced today that the clinical...

Monday, May 10, 2021, 10:14:00 AM

Denmark to Begin Offering Covid-19 ‘Vaccine Passport’ for Travelers in Early 2021

As the coronavirus pandemic continues to spiral out of control and decimate air travel around...

Thursday, January 14, 2021, 04:01:00 PM